Hiroki Taguchi

Rb Loss and <i>KRAS</i> Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo et al. · Clinical Cancer Research · 2017 · 181 citations

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

Laurent Peyrin‐Biroulet, Jessica R. Allegretti, David T. Rubin et al. · Gastroenterology · 2023 · 86 citations · Full text

Aberrant methylation of <i>MUC1</i> and <i>MUC4</i> promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas

Seiya Yokoyama, Michiyo Higashi, Sho Kitamoto et al. · Oncotarget · 2016 · 54 citations · Full text

Potential Prognostic Biomarkers, Epigenetic Change, Pathology +23

Effect of Endoscopic Submucosal Dissection for Superficial Esophageal Neoplasms and Risk Factors for Postoperative Stricture

Keita Funakawa, Hirofumi Uto, Fumisato Sasaki et al. · Medicine · 2015 · 51 citations · Full text

Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately

Tsukasa Yoshida, Susumu Hijioka, Waki Hosoda et al. · Annals of Surgical Oncology · 2019 · 51 citations

Surgical Oncology, Carcinoma G3, Pancreatic Cancer +7